Upon completion of this activity, participants should be able to assess the current use of FDA-approved biologic agents for the treatment of psoriatic arthritis in your practice and identify opportunities to better educate patients about drug efficacy and safety to improve overall adherence.
The 2018 Conference Enduring Course consists of a series of videos from passionate experts that presented at the 2018 11th Annual RNS Conference in Fort Worth, Texas.
We will look at the association between obesity and rheumatoid arthritis and how the presence of excess weight impacts patient experience and response to disease modifying anti-rheumatic drug therapy. We will also briefly address current thinking surrounding the “obesity paradox.” Lastly, we will explore approaches to weight loss in patients who are overweight or obese and the general benefits of weight loss in this population.
We will provide an introductory level description of the basic immunology and pathophysiology of systemic lupus erythematosus (SLE) that will allow rheumatology nurses and nurse practitioners to better understand and explain key concepts of SLE to their patients.
We will examine new insights into the pathophysiology of spondyloarthritis (SpA) that have led to changes in disease classification systems. This issue will also explore how the common underlying pathology of SpA subtypes leads to the diverse clinical manifestations.